- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of human papillomavirus vaccines: a review
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 14, Issue 5, Pages 697-712
Publisher
Informa Healthcare
Online
2015-02-18
DOI
10.1517/14740338.2015.1013532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- On the relationship between human papilloma virus vaccine and autoimmune diseases
- (2014) Paolo Pellegrino et al. AUTOIMMUNITY REVIEWS
- Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women
- (2014) E. M. Kojic et al. CLINICAL INFECTIOUS DISEASES
- Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: Results from a randomized controlled trial
- (2014) Feng-Cai Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Quadrivalent Human Papillomavirus Vaccine and the Risk of Venous Thromboembolism
- (2014) Nikolai Madrid Scheller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
- (2014) S Rachel Skinner et al. LANCET
- Long-term Immunogenicity and Safety of the HPV-16/18 AS04-adjuvanted Vaccine in 10- to 14-year-old Girls
- (2014) Tino F. Schwarz et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme
- (2014) Maria-Genalin Angelo et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience
- (2014) Maria-Genalin Angelo et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil™ in Adult Women
- (2014) Joaquin Luna et al. PLoS One
- Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults
- (2014) Vania Giacomet et al. VACCINE
- Adverse events following immunization in Ontario's female school-based HPV program
- (2014) Tara Harris et al. VACCINE
- Childhood vaccination associated adverse events by sex: A literature review
- (2014) Sandra Köhli Weber et al. Travel Medicine and Infectious Disease
- Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
- (2014) Paulo S Naud et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and Safety of the Human Papillomavirus 6, 11, 16, 18 Vaccine in HIV-Infected Young Women
- (2013) Jessica A. Kahn et al. CLINICAL INFECTIOUS DISEASES
- Human papillomavirus vaccine and systemic lupus erythematosus
- (2013) Mariele Gatto et al. CLINICAL RHEUMATOLOGY
- Safety of Human Papillomavirus Vaccines: A Review
- (2013) Kristine K. Macartney et al. DRUG SAFETY
- Comparison of the Immunogenicity and Reactogenicity of Cervarix and Gardasil Human Papillomavirus Vaccines in HIV-Infected Adults: A Randomized, Double-Blind Clinical Trial
- (2013) L. Toft et al. JOURNAL OF INFECTIOUS DISEASES
- Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects
- (2013) L. Grimaldi-Bensouda et al. JOURNAL OF INTERNAL MEDICINE
- Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years
- (2013) Arzu Soybilgic et al. Pediatric Rheumatology
- Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: A systematic review
- (2013) Lisa Rambout et al. PREVENTIVE MEDICINE
- HPV vaccine acceptability among men: a systematic review and meta-analysis
- (2013) Peter A Newman et al. SEXUALLY TRANSMITTED INFECTIONS
- Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study
- (2013) Lynette Denny et al. VACCINE
- Safety of the quadrivalent human papillomavirus vaccine
- (2013) J. M. L. Brotherton BMJ-British Medical Journal
- Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
- (2013) L. Arnheim-Dahlstrom et al. BMJ-British Medical Journal
- Guillain–Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States
- (2013) Rohit P Ojha et al. Human Vaccines & Immunotherapeutics
- Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women
- (2013) Miriam Levi et al. Human Vaccines & Immunotherapeutics
- Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine
- (2012) Alexandros Sotiriadis et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females
- (2012) Nicola P. Klein et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Systemic lupus erythematosus following HPV immunization or infection?
- (2012) HF Soldevilla et al. LUPUS
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis
- (2011) Beibei Lu et al. BMC INFECTIOUS DISEASES
- End-of-study safety, immunogenicity and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
- (2011) X Castellsagué et al. BRITISH JOURNAL OF CANCER
- Papillomavirus virus like particle-based therapeutic vaccine against human papillomavirus infection related diseases: Immunological problems and future directions
- (2011) Jiezhong Chen et al. CELLULAR IMMUNOLOGY
- Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old
- (2011) Richard J. Hillman et al. Clinical and Vaccine Immunology
- Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine
- (2011) Karly P. Garnock-Jones et al. DRUGS
- Safety and tolerability of bivalent HPV vaccine: An Italian post-licensure study
- (2011) Roberto Gasparini et al. Human vaccines & immunotherapeutics
- Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine
- (2011) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Safety and Immunogenicity Profile of Human Papillomavirus-16/18 AS04 Adjuvant Cervical Cancer Vaccine: A Randomized Controlled Trial in Healthy Adolescent Girls of Bangladesh
- (2011) S. Khatun et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
- (2011) C. Chao et al. JOURNAL OF INTERNAL MEDICINE
- For Cancers Caused by HPV, Two Vaccines Were Just the Beginning
- (2011) J. Peres JNCI-Journal of the National Cancer Institute
- The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety
- (2011) J. Baggs et al. PEDIATRICS
- Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands
- (2011) T.M. van’t Klooster et al. VACCINE
- Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
- (2011) Julianne Gee et al. VACCINE
- Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women
- (2010) Tiina Petäjä et al. INTERNATIONAL JOURNAL OF CANCER
- Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine in HIV-Infected Children 7 to 12 Years Old
- (2010) Myron J Levin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls
- (2010) Doris M. Rivera Medina et al. JOURNAL OF ADOLESCENT HEALTH
- Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected Men
- (2010) Timothy Wilkin et al. JOURNAL OF INFECTIOUS DISEASES
- HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future
- (2010) Luciano Mariani et al. Journal of Translational Medicine
- Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine
- (2010) Stan L. Block et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance
- (2010) Michael S. Gold et al. Sexual Health
- Comment on the contribution by Souayah et al., “Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009”
- (2010) Barbara A. Slade et al. VACCINE
- Guillain–Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006–2009
- (2010) Nizar Souayah et al. VACCINE
- Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆
- (2009) Marie-Pierre David et al. GYNECOLOGIC ONCOLOGY
- Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
- (2009) Barbara A. Slade JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial
- (2009) Nubia Muñoz et al. LANCET
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far
- (2009) Theodoros Agorastos et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now